Skip to content

A Systematic Literature Review of the Effectiveness of Mindfulness-Based Cognitive Therapy on Depression Among Older People

Helena Patricia, Sharifah Munirah Syed Elias, Noor Azizah Binti Mohd Ali, Hema Malini

Jurnal Kesehatan March 31, 2025 DOI: 10.35730/jk.v16i1.1229 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Systematic review Peer reviewed
Population Older adults with depression
Intervention Mindfulness-Based Cognitive Therapy (MBCT)
Topics Depression Meditation
Key findings The review concludes that MBCT is beneficial in alleviating depression among older adults and may serve as a potential alternative therapy. The authors caution that future research must demonstrate stronger structural quality and use larger sample sizes.

Abstract

The worldwide population of older people is rising rapidly, with projections suggesting that by 2050, persons aged 60 and over will represent 22% of the entire population. Age-related outcomes are significantly exacerbated by frailty, susceptibility, and an elevated risk of depression. Mindfulness-Based Cognitive Therapy (MBCT) has become a feasible therapeutic approach, integrating cognitive therapy with mindfulness techniques. This review systematically assesses the efficacy of MBCT in alleviating depression in the older population. This review adheres to PRISMA criteria. Seven databases (Medline, Scopus, ClinicalKey for Nursing, Ebsco, Web of Science, Cochrane Library, and Grey Literature) were examined from 2017 to 2022. Three keywords utilized were depression, elderly individuals, and MBCT. The quality of the studies was assessed using the Joanna Briggs Institute's (JBI) critical appraisal tool. Eleven studies were incorporated for the review. Research demonstrates that MBCT is advantageous in alleviating depression among the older population. This review indicates that MBCT is a potential alternative therapy for older individuals experiencing depression. It is imperative to emphasise that future research must demonstrate enhanced structural quality and require larger sample sizes.

Comparable studies

Other systematic reviews and meta-analyses on depression, most cited first.

Study Year Design Participants
Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression Participants with major depression in placebo-controlled, double-blind, randomized... 2015 Systematic review and meta-analysis
Side-effects associated with ketamine use in depression: a systematic review. Patients with depression 2018 Systematic review
Comparative efficacy of racemic ketamine and esketamine for depression: a systematic review and meta-analysis Adults with unipolar or bipolar major depression 2020 Systematic review and meta-analysis n = 1,877
Single-dose infusion ketamine and non-ketamine N-methyl-D-aspartate receptor antagonists for unipolar and bipolar depression: a meta-analysis of efficacy, safety and time trajectories Patients with major depressive disorder or bipolar depression 2016 Systematic review and meta-analysis n = 588
Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern‐era clinical studies Patients with cancer- or illness-related anxiety and depression, major depressive... 2020 Systematic review n = 188

Explore topics